Our newest #EAUUrologyCheatSheets is a collaborative effort with @ASCO to create comprehensive guidelines on #PenileCancer. Review the updated #EAUGuidelines on #PenileCarcinoma with this one page
BCG is an effective treatment for high-risk non-muscle invasive bladder tumors, with response rates of around 70%. However, progression during BCG treatment can occur in
Standard treatment for urothelial muscle invasive bladder cancer is radical cystectomy (RC), but RC only provides 5-year survival in ~50% of patients. Review the #EAUGuidelines
The majority of renal cell carcinomas (RCCs) are detected incidentally by noninvasive imaging investigating non-specific symptoms and other abdominal diseases. Review the #EAUGuidelines on how
In the evaluation of patients with prostate cancer, an adequate initial assessment and tumour extension is crucial for an adequate management of the disease. Knowing
Radiotherapy (RT) is an alternative treatment for localized prostate cancer (PC) with the same cure rates as radical prostatectomy (RP). Radiation dose is directly related
In managing Testicular Cancer, careful staging at diagnosis, early treatment, rigorous follow-up and salvage therapies are critical to successful outcomes. Check the #EAUGuidelines on disease
In recent years, different combinations of #systemictherapy for metastatic hormone-sensitive #prostatecancer (mHSPC) with doublet and even triple therapy have been introduced with different results in
Review #EAUGuidelines on Upper Urinary Tract Urothelial Cell Carcinoma (#UTUC) with this #EAUUrologyCheatSheets! See the newest recommendations for both metastatic and non-metastatic disease management.
Bladder cancer is the 7th most commonly diagnosed cancer in males, and ~75% of patients have non-muscle-invasive bladder carcinomas (#NMIBC). Review the #EAUGuidelines on staging
Paseo del General Martínez Campos, 17, 28010 Madrid
